Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes. (Q52149077)
Jump to navigation
Jump to search
scientific article published on 17 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes. |
scientific article published on 17 September 2015 |
Statements
Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes (English)
Cristina Hernández
Lidia Corraliza
Cristina Solà-Adell
José A Arranz
Ana I Arroba
Angela M Valverde
17 September 2015